SCHEMBL5529092

SCHEMBL5529092

COc1ccc([N]C=O)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.52
CYP2A6 P11509 1/20 0.52
CA12 O43570 2/20 0.50
CA2 P00918 2/20 0.50
CA9 Q16790 2/20 0.50
CA1 P00915 1/20 0.50
CA7 P43166 1/20 0.50
CA14 Q9ULX7 1/20 0.50
NOS3 P29474 2/20 0.47
HTR3E A5X5Y0 1/20 0.47
HTR3B O95264 1/20 0.47
HTR3A P46098 1/20 0.47
HTR3D Q70Z44 1/20 0.47
HTR3C Q8WXA8 1/20 0.47
ACHE P22303 2/20 0.44
PTGS2 P35354 3/20 0.44
TP53 P04637 1/20 0.44
TSHR P16473 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
S100B P04271 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5533359 0.77 NQO1 (0.56) ALDH1A1CA12CA2CA9CA1
SCHEMBL11735292 0.75 HTR3E (0.53) ALDH1A1CA2CA9CA1CA7
SCHEMBL5526344 0.74 LTA4H (0.50) CA2CA9CA1TSHRKMT2A
SCHEMBL14459430 0.74 S100B (0.49) ALDH1A1CYP2A6CA12CA2CA9
SCHEMBL5419235 0.73 CYP2A6 (0.46) ALDH1A1CYP2A6CA12CA2CA9
SCHEMBL156005 0.73 CA1 (0.58) ALDH1A1CYP2A6CA12CA2CA9
SCHEMBL161063 0.73 CYP3A4 (0.50) ALDH1A1CYP2A6CA12CA2CA9
SCHEMBL5798418 0.72 NQO2 (0.57) ALDH1A1CYP2A6CA12CA2CA9
1,4-Dimethoxybenzene SCHEMBL28866433 0.72 CA1 (0.65) ALDH1A1CYP2A6CA12CA2CA9
SCHEMBL1405603 0.72 CA1 (0.65) CA12CA2CA9CA1CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7241770-B2 Hydronopol derivatives as agonists on human ORL1 receptors SOLVAY PHARMACEUTICALS GMBH (DE) 2007-07-10 US disclosed
US-20050131004-A1 Hydronopol derivatives as agonists on human ORL1 receptors SOLVAY PHARMACEUTICALS GMBH. 2005-06-16 US disclosed
US-4054585-A FUNGICIDES, INSECTICIDES UNIROYAL, INC. (US) 1977-10-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050131004-A1 Hydronopol derivatives as agonists on human ORL1 receptors OPRL1, ORMDL3, OGFRL1 ALDH1A1 498/4885CYP2A6 2239/4885CA12 4362/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.